|
gptkbp:instanceOf
|
anthelmintic drug
benzimidazole
|
|
gptkbp:administeredBy
|
gptkb:dog
gptkb:livestock
cats
horses
rabbits
goats
|
|
gptkbp:ATCCode
|
QP52AC13
|
|
gptkbp:brand
|
gptkb:Panacur
gptkb:Safe-Guard
|
|
gptkbp:CASNumber
|
43210-67-9
|
|
gptkbp:chemicalFormula
|
benzimidazole ring with thioether and carbamate groups
|
|
gptkbp:compatibleWith
|
human use in the United States
|
|
gptkbp:discoveredBy
|
gptkb:Hoechst_AG
|
|
gptkbp:eliminationHalfLife
|
~5 hours (in dogs)
|
|
gptkbp:excretion
|
primarily fecal
|
|
gptkbp:hasMolecularFormula
|
C15H13N3O2S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
fenbendazole
|
|
gptkbp:introducedIn
|
1974
|
|
gptkbp:legalStatus
|
veterinary use only
|
|
gptkbp:mechanismOfAction
|
inhibits microtubule formation
|
|
gptkbp:metabolism
|
oxfendazole
|
|
gptkbp:molecularWeight
|
299.35 g/mol
|
|
gptkbp:pregnancyCategory
|
N (not classified)
|
|
gptkbp:relatedTo
|
gptkb:albendazole
gptkb:mebendazole
gptkb:flubendazole
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
rare gastrointestinal upset
|
|
gptkbp:solubility
|
poorly soluble in water
|
|
gptkbp:usedFor
|
treatment of giardiasis
treatment of parasitic worm infestations
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
|
|
gptkbp:bfsParent
|
gptkb:Encephalitozoon_cuniculi
|
|
gptkbp:bfsLayer
|
6
|